Stan Berenshteyn
Stock Analyst at Wells Fargo
(1.05)
# 3,913
Out of 4,703 analysts
305
Total ratings
50.3%
Success rate
-1.1%
Average return
Main Sectors:
Stocks Rated by Stan Berenshteyn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HQY HealthEquity | Reiterated: Buy | $125 | $98.78 | +26.54% | 58 | Sep 4, 2026 | |
| PHR Phreesia | Rated: Hold | $9 → $10 | $11.10 | -9.91% | 7 | Sep 3, 2026 | |
| VEEV Veeva Systems | Maintained: Buy | $320 | $284.38 | +12.53% | 43 | Aug 27, 2026 | |
| PGNY Progyny | Initiated Coverage: Buy | $37 | $26.61 | +39.05% | 1 | Aug 20, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $33 | $26.08 | +26.53% | 4 | Aug 19, 2026 | |
| HCAT Health Catalyst | Rated: Hold | $1.75 → $1.5 | $1.71 | -12.28% | 27 | Aug 13, 2026 | |
| CTEV Claritev | Maintained: Hold | $22 → $30 | $39.09 | -23.25% | 4 | Aug 12, 2026 | |
| DOCS Doximity | Downgraded: Sell | $18 | $27.10 | -33.58% | 34 | Aug 10, 2026 | |
| AMWL American Well | Maintained: Buy | $16 | $13.25 | +20.75% | 18 | Aug 5, 2026 | |
| OMCL Omnicell | Rated: Buy | $55 → $50 | $34.82 | +43.60% | 55 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $6.47 | -7.26% | 9 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $90 | $90.76 | -0.84% | 5 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.5 | $3.53 | -0.85% | 35 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $22.29 | -19.25% | 4 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $16.76 | n/a | 1 | Oct 6, 2015 |
HealthEquity
Sep 4, 2026
Reiterated: Buy
Price Target: $125
Current: $98.78
Upside: +26.54%
Phreesia
Sep 3, 2026
Rated: Hold
Price Target: $9 → $10
Current: $11.10
Upside: -9.91%
Veeva Systems
Aug 27, 2026
Maintained: Buy
Price Target: $320
Current: $284.38
Upside: +12.53%
Progyny
Aug 20, 2026
Initiated Coverage: Buy
Price Target: $37
Current: $26.61
Upside: +39.05%
Waystar Holding
Aug 19, 2026
Maintained: Buy
Price Target: $33
Current: $26.08
Upside: +26.53%
Health Catalyst
Aug 13, 2026
Rated: Hold
Price Target: $1.75 → $1.5
Current: $1.71
Upside: -12.28%
Claritev
Aug 12, 2026
Maintained: Hold
Price Target: $22 → $30
Current: $39.09
Upside: -23.25%
Doximity
Aug 10, 2026
Downgraded: Sell
Price Target: $18
Current: $27.10
Upside: -33.58%
American Well
Aug 5, 2026
Maintained: Buy
Price Target: $16
Current: $13.25
Upside: +20.75%
Omnicell
Jul 30, 2026
Rated: Buy
Price Target: $55 → $50
Current: $34.82
Upside: +43.60%
Jul 30, 2026
Maintained: Hold
Price Target: $6
Current: $6.47
Upside: -7.26%
Jun 24, 2026
Rated: Buy
Price Target: $80 → $90
Current: $90.76
Upside: -0.84%
Jun 2, 2026
Maintained: Buy
Price Target: $3.5
Current: $3.53
Upside: -0.85%
May 8, 2026
Maintained: Hold
Price Target: $17 → $18
Current: $22.29
Upside: -19.25%
Oct 6, 2015
Initiated Coverage: Buy
Price Target: $34
Current: $16.76
Upside: n/a